Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

A systematic approach is crucial for managing hair loss in women.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Environmental and cosmetic factors, including heat, chemicals, and sun exposure, can cause hair loss and damage.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Washing test helps identify hair loss type, low iron levels significant.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

Hair loss from telogen effluvium may not happen again after another surgery.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.